# MidCap Financial Investment Corp: financial statements, quarterly

MFIC · Nasdaq · CIK 1278752 · [Other](/sectors/other.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mfic.md) · [Financials](/companies/mfic/financials.md) · [Filings](/companies/mfic/filings.md) · [Insiders](/companies/mfic/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mfic/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [26.3](/filings/0000950170-23-060325.md) | [27.2 d](/filings/0000950170-24-020118.md) | [26.2](/filings/0000950170-24-054445.md) | [27.0](/filings/0000950170-24-092876.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net income | $m | [30.0](/filings/0000950170-24-122744.md) | [33.3](/filings/0000950170-24-020118.md) | [25.5](/filings/0000950170-25-069131.md) | [22.6](/filings/0000950170-25-106526.md) | [26.7](/filings/0001193125-25-269512.md) | [24.1 d](/filings/0001193125-26-076499.md) | [30.3](/filings/0001193125-26-208941.md) | [18.1](/filings/0001193125-26-335848.md) | [27.5](/filings/0001193125-25-269512.md) | [(12.7) d](/filings/0001193125-26-076499.md) | [(26.9)](/filings/0001193125-26-208941.md) | [(17.5)](/filings/0001193125-26-335848.md) |
| Basic EPS | $ per share | [0.46](/filings/0000950170-24-122744.md) | not reported | [0.39](/filings/0000950170-25-069131.md) | [0.35](/filings/0000950170-25-106526.md) | [0.31](/filings/0001193125-25-269512.md) | not reported | [0.32](/filings/0001193125-26-208941.md) | [0.19](/filings/0001193125-26-335848.md) | [0.29](/filings/0001193125-25-269512.md) | not reported | [(0.30)](/filings/0001193125-26-208941.md) | [(0.21)](/filings/0001193125-26-335848.md) |

- Interest expense: us-gaap:InterestExpense
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [43.0](/filings/0000950170-23-060325.md) | [93.6](/filings/0000950170-25-026688.md) | [49.6](/filings/0000950170-24-054445.md) | [66.2](/filings/0000950170-24-092876.md) | [84.5](/filings/0000950170-24-122744.md) | [74.4](/filings/0001193125-26-076499.md) | [83.7](/filings/0000950170-25-069131.md) | [69.0](/filings/0000950170-25-106526.md) | [62.5](/filings/0001193125-25-269512.md) | [98.2](/filings/0001193125-26-335848.md) | [42.6](/filings/0001193125-26-208941.md) | [43.3](/filings/0001193125-26-335848.md) |
| Total assets | $m | [2,455](/filings/0000950170-23-060325.md) | [2,501](/filings/0000950170-25-026688.md) | [2,445](/filings/0000950170-24-054445.md) | [2,551](/filings/0000950170-24-092876.md) | [3,216](/filings/0000950170-24-122744.md) | [3,191](/filings/0001193125-26-076499.md) | [3,356](/filings/0000950170-25-069131.md) | [3,462](/filings/0000950170-25-106526.md) | [3,309](/filings/0001193125-25-269512.md) | [3,324](/filings/0001193125-26-335848.md) | [3,070](/filings/0001193125-26-208941.md) | [2,861](/filings/0001193125-26-335848.md) |
| Total liabilities | $m | [1,458](/filings/0000950170-23-060325.md) | [1,496](/filings/0000950170-25-026688.md) | [1,439](/filings/0000950170-24-054445.md) | [1,547](/filings/0000950170-24-092876.md) | [1,800](/filings/0000950170-24-122744.md) | [1,786](/filings/0001193125-26-076499.md) | [1,962](/filings/0000950170-25-069131.md) | [2,086](/filings/0000950170-25-106526.md) | [1,942](/filings/0001193125-25-269512.md) | [2,016](/filings/0001193125-26-335848.md) | [1,894](/filings/0001193125-26-208941.md) | [1,759](/filings/0001193125-26-335848.md) |
| Long-term debt | $m | [1,434](/filings/0000950170-23-060325.md) | [1,752](/filings/0000950170-25-069131.md) | [1,405](/filings/0000950170-24-054445.md) | [1,512](/filings/0000950170-24-092876.md) | [1,773](/filings/0000950170-24-122744.md) | [1,752](/filings/0001193125-26-076499.md) | [1,935](/filings/0000950170-25-069131.md) | [2,052](/filings/0000950170-25-106526.md) | [1,915](/filings/0001193125-25-269512.md) | [1,995](/filings/0001193125-26-335848.md) | [1,870](/filings/0001193125-26-208941.md) | [1,740](/filings/0001193125-26-335848.md) |
| Shareholders' equity | $m | not reported | not reported | not reported | not reported | not reported | [1,405](/filings/0001193125-26-076499.md) | not reported | [1,376](/filings/0001193125-26-335848.md) | not reported | [1,307](/filings/0001193125-26-335848.md) | [1,176](/filings/0001193125-26-208941.md) | [1,101](/filings/0001193125-26-335848.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [63.8 d](/filings/0000950170-24-122744.md) | [78.4 d](/filings/0001193125-26-076499.md) | [9.4](/filings/0000950170-25-069131.md) | [(63.5) d](/filings/0000950170-25-106526.md) | [(10.1) d](/filings/0001193125-25-269512.md) | [54.8 d](/filings/0001193125-26-076499.md) | [(131)](/filings/0001193125-26-208941.md) | [(91.0) d](/filings/0001193125-26-335848.md) | [166 d](/filings/0001193125-25-269512.md) | [6.3 d](/filings/0001193125-26-076499.md) | [169](/filings/0001193125-26-208941.md) | [189 d](/filings/0001193125-26-335848.md) |
| Dividends paid | $m | [24.8 d](/filings/0000950170-24-122744.md) | [24.8 d](/filings/0001193125-26-076499.md) | [24.8](/filings/0000950170-25-069131.md) | [24.8 d](/filings/0000950170-25-106526.md) | [54.4 d](/filings/0001193125-25-269512.md) | [35.6 d](/filings/0001193125-26-076499.md) | [35.6](/filings/0001193125-26-208941.md) | [35.5 d](/filings/0001193125-26-335848.md) | [35.5 d](/filings/0001193125-25-269512.md) | [35.0 d](/filings/0001193125-26-076499.md) | [28.1](/filings/0001193125-26-208941.md) | [25.5 d](/filings/0001193125-26-335848.md) |
| Share repurchases | $m | [0.0 d](/filings/0000950170-24-122744.md) | [0.0 d](/filings/0001193125-26-076499.md) | not reported | not reported | not reported | not reported | [6.1](/filings/0001193125-26-208941.md) | [0.0 d](/filings/0001193125-26-335848.md) | [0.0 d](/filings/0001193125-25-269512.md) | [12.9 d](/filings/0001193125-26-076499.md) | [76.0](/filings/0001193125-26-208941.md) | [31.9 d](/filings/0001193125-26-335848.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

Shares outstanding: 82,372,628 at 2026-08-05, from the cover of the [10-Q filed 2026-08-06](/filings/0001193125-26-335848.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.